About 1,831 Trademarks found that are filed by the attorney MartIn J Beran

Medical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology

Food supplements and dietetic substances, namely, food additives for non-medical use containing carbohydrates and fibers used for non-nutritional purposes

Pharmaceutical preparations for the treatment of constipation; pharmaceutical preparations for the treatment of metabolic disorders; laxatives; dietetic foods adapted for medical use

The color(s) light green, green and dark green is/are claimed as a feature of the mark.

The mark consists of stripes forming an arrow pointing left. From left to right, the first two stripes are dark orange, the next three stripes are orange and the last three stripes are light orange.

Medical and scientific research in the field of immunology, oncology and immuno-oncology; providing medical and scientific research information in the field of immunology, oncology and immuno-oncology

The mark consists of the wording "BUGLIONI" and a combination of lines, dotted lines, and dots forming the letter "B".

Alcoholic beverages except beers

The mark consists of the stylized wording "EMPA-VISION" in black capital letters, except for the letter "O" which consists of multiple circles in various sizes in the colors purple, blue, and red. In the center of the "O" is a red heart. The color white is used as background.

educational services, namely, conducting training for professionals in the medical and pharmaceutical field of oncology

The mark consists of the following: Blue, green, red, orange, white and gray atom like circles attached with gray lines in the shape of a lightbulb. In the center of the bulb is a large orange circle. The base of the bulb is white and gray. The remaining white in the mark is for background purposes and is not part of the mark.

Veterinary preparations, namely, preparations for the treatment of metabolic diseases; veterinary preparations for the treatment of cardiovascular disease; veterinary preparations for the treatment of central nervous system diseases and disorders and central nervous system movement disorders; veterinary preparations for the treatment of neurological diseases and disorders, namely, brain injury; veterinary preparations for the treatment of musculoskeletal diseases and disorders, bone diseases; veterinary preparations for the treatment of hormonal diseases; anti-infectives, namely, veterinary preparations against bacterial infections; veterinary preparations, namely, vaccines; all of the foregoing excluding, pharmaceutical preparations, medicines, and medication for human use